Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

Innovative Medical

Status and phase: Completed; Phase 4

Conditions: Vitrectomy

Treatments: Drug: Nepafenac; Drug: Ketorolac LS, Bromfenac

Study type: Interventional

Funder types: Industry

Identifiers

NCT00377546

5264

Details and patient eligibility

About

To compare the penetration of three different NSAIDs.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Males or females scheduled to undergo Vitrectomy surgery
• Likely to complete all study visits and able to provide informed consent
• Visual potential of 20/25 or better

Exclusion criteria

• Known contraindications to any study medication or ingredients
• Active ocular diseases or uncontrolled systemic disease
• Active ocular allergies